Cargando…
Decreased Serum Levels of Interleukin-4 and Interleukin-21 in New Pemphigus Vulgaris Patients, but Not Chronic Patients With Inactive Disease Compared to Healthy Controls
BACKGROUND: Pemphigus is a rare group of autoimmune blistering diseases with unknown etiology and unclear pathogenesis. Pemphigus vulgaris (PV) is the most common subtype, and is characterized by ulcerations or flaccid blisters on mucous membranes and on the skin. It is accepted that cytokines have...
Autores principales: | Shahbazian, Pegah, Izad, Maryam, Daneshpazhooh, Maryam, Mortazavi, Hossein, Salehi, Zahra, Behruzifar, Shirin, Tavakolpour, Soheil, Azizpour, Arghavan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mattioli 1885
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060009/ https://www.ncbi.nlm.nih.gov/pubmed/33954018 http://dx.doi.org/10.5826/dpc.1102a35 |
Ejemplares similares
-
Koebner phenomenon in pemphigus vulgaris patients
por: Balighi, Kamran, et al.
Publicado: (2016) -
Elevated Serum Levels of Interleukin-15 in Pemphigus Vulgaris Patients: a Potential Therapeutic Target
por: Kheirodin, Maedeh, et al.
Publicado: (2022) -
Short-term clinical and serological follow-up with conventional and conformational anti-desmoglein antibodies in treatment-naïve and previously treated patients with pemphigus vulgaris after receiving rituximab
por: Alaeen, Hoorieh, et al.
Publicado: (2019) -
Rituximab therapy improves recalcitrant Pemphigus vulgaris
por: Noormohammadpour, Pedram, et al.
Publicado: (2015) -
Estimated cut-off values for pemphigus severity classification according to pemphigus disease area index (PDAI), autoimmune bullous skin disorder intensity score (ABSIS), and anti-desmoglein 1 autoantibodies
por: Mohebi, Farnam, et al.
Publicado: (2020)